文献速递腹部CT

可切除胃癌CT影像特征与临床分期对预后风险分层的比较:多中心研究

CT imaging features in prognostic risk stratification compared to clinical staging in resectable gastric cancer: a multicenter study.
PubMed 文献 · Abdom Radiol (NY) · 2026-10-30

本研究回顾性纳入886例接受根治性胃切除术的胃癌患者,评估可视觉评估的CT特征在临床分期基础上对无病生存(DFS)的增量预后价值。开发队列中,CT影像评分(CIS)加入cStage后C-index从0.648提升至0.805,1、3、5年AUC分别提高0.159、0.184、0.193;外部验证中联合模型C-index为0.695。CIS-high状态在cStage II和III内均与更差DFS相关。

要点

  • 可视觉评估的CT特征可提升胃癌术前临床分期的DFS预后判别能力
  • CIS-high在cStage II和III内均提示更差DFS,有助于术前风险细化
  • 外部验证中联合模型C-index为0.695,判别能力有限

核心结论

  • 将可视觉评估的CT影像特征与常规cStage整合,在开发队列中改善了DFS预后判别,且衍生的CIS可在术前cStage分层内进一步细化风险分层。

研究设计与样本

  • 多中心回顾性研究,纳入886例接受根治性胃切除术的患者,开发队列698例,外部验证队列188例。
  • 临床与病理分期按AJCC第8版重建并简化为三个层级。
  • 评估临床分期模型、CT影像模型和联合模型的判别力、校准度、bootstrap校正性能及外部验证,并以C-index变化和时间依赖AUC评估增量预后价值。

诊断标准与关键数值

  • 开发队列中,cStage与pStage的一致性为51.0%(线性加权κ=0.387),外部队列为61.2%(线性加权κ=0.513)。
  • 开发队列中,cStage加入CIS后C-index从0.648升至0.805(ΔC-index=0.160,P=0.002),1年、3年、5年AUC分别提高0.159、0.184、0.193(均P=0.001)。
  • 联合模型经乐观度校正后C-index为0.797;外部验证中临床分期、CT影像和联合模型的C-index分别为0.676、0.694和0.695。
  • 开发队列中,CIS-high状态在cStage II内与更差DFS相关(HR=8.66,95%CI:5.59-13.42),在cStage III内亦相关(HR=5.78,95%CI:3.74-8.92),校正术后pStage后关联仍存在。

临床应用与阅片要点

  • 阅片时可关注可视觉评估的CT特征并形成CIS评分,辅助术前cStage分层内的DFS风险细化。
  • 注意cStage与pStage一致性仅约51.0%–61.2%,术前分期存在一定偏差,联合CT特征可能弥补部分不足。
  • 外部验证C-index约0.695,提示模型判别能力有限,临床决策需结合其他因素。

局限性

  • 回顾性研究设计。
  • 外部验证队列样本量较小(n=188),联合模型外部C-index仅0.695。
  • CIS cutoff为开发队列衍生并锁定,需进一步外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the incremental prognostic value of visually assessable CT features beyond clinical stage (cStage) for disease-free survival (DFS) risk stratification in gastric cancer.

METHODS: Patients undergoing curative gastrectomy were retrospectively included in development and external cohorts. Clinical and pathological stages were reconstructed according to the AJCC 8th edition and simplified to three tiers. Clinical Stage, CT Imaging, and Combined models were evaluated for discrimination, calibration, bootstrap-corrected performance, and external validation. Incremental prognostic value was assessed using changes in the C-index and time-dependent AUCs. A development-derived CT Imaging Score (CIS) cutoff was locked for exploratory risk refinement within preoperative cStage strata.

RESULTS: Among 886 patients (development, n = 698; external, n = 188), cStage-pStage concordance was 51.0% and 61.2%, respectively (linear-weighted κ = 0.387 and 0.513). In the development cohort, adding CIS to cStage increased the C-index from 0.648 to 0.805 (ΔC-index = 0.160, P = 0.002) and the 1-, 3-, and 5-year AUCs by 0.159, 0.184, and 0.193, respectively (all P = 0.001). The optimism-corrected C-index was 0.797 for the Combined model. External C-indices were 0.676, 0.694, and 0.695 for the Clinical Stage, CT Imaging, and Combined models, respectively. In the development cohort, CIS-high status was associated with worse DFS within cStage II (HR = 8.66, 95% CI: 5.59-13.42) and cStage III (HR = 5.78, 95% CI: 3.74-8.92), with associations retained after adjustment for postoperative pStage.

CONCLUSION: Integrating visually assessable CT imaging features with conventional cStage improved DFS prognostic discrimination in the development cohort, while the derived CIS further refined risk stratification within preoperative cStage groups.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zhang, Tang, Liu, et al. CT imaging features in prognostic risk stratification compared to clinical staging in resectable gastric cancer: a multicenter study. Abdom Radiol (NY). 2026. PMID: 42961641. doi:10.1007/s00261-026-05832-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。